EUVIMEDEUVIMED entdecken
Crossref

Chronic kidney disease G3–5 in lupus nephritis—prevalence, progression, and risk factors

Selene T Y Teoh, Desmond Y H Yap, Colin S O Tang, Tak Mao Chan iD

Nephrology Dialysis Transplantation · 2026

DOI: 10.1093/ndt/gfaf201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, 2026. Verfasst von Selene T Y Teoh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, School of Clinical Medicine, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR. Hauptthemen laut MEDLINE: Lupus Nephritis, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Yu Chiu-Kwong Endowed Professorship in Medicine, Wai Hung Charitable Foundation, Mr and Mrs Tam Wing Fun Edmund Renal Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite treatment advances, there are limited data on the development of chronic kidney disease (CKD) in patients with lupus nephritis (LN) on long-term follow up. In this study, we aim to investigate the prevalence of CKD, its progression over time, and associated risk factors in patients with LN.

Methods

We conducted a retrospective study on Chinese patients with biopsy-proven LN diagnosed in 1981–2017. CKD G3–5 was defined according to an estimated glomerular filtration rate (eGFR) of <60 ml/min/m2, for >3 months. Risk factors for CKD progression and adverse outcomes were determined by multivariate logistic regression.

Results

In total, 183 patients were included. Over a mean follow up of 19.9 ± 9.7 years, 34.4% (63 patients) developed CKD G3–5, 9.8% developed kidney failure (KF) and 14.2% died. CKD G3-5 was associated with older age, renal impairment and hypertension at presentation, and the occurrence of nephritis flares. eGFR <60 ml/min/1.73 m2 was present in 24.6% of patients at presentation, and the prevalence decreased to 13.6% and 12% after 6 and 12 months of treatment, respectively, followed by a gradual increase to 15.3%, 16.4%, and 20.8% after 2, 5, and 10 years of follow up, respectively. In multivariate analysis, eGFR <80 ml/min/1.73 m2 at 1 year [OR 16.684 (95% CI 4.305–64.660), P < .001] and ≥2 nephritis flares [OR 7.237 (95% CI 2.041–25.919), P = .002] were significant predictors of CKD G3–5 development and adverse clinical outcomes during follow up. Continuous induction-maintenance treatment with mycophenolate and glucocorticoid was associated with reduced risk of CKD G3–5 at 10-years [OR 0.196 (95% CI 0.046–0.835), P = .028].

Conclusion

CKD G3–5 is common, affecting approximately one-fifth of LN patients after 10 years of follow up. eGFR <80 ml/min/1.73 m2 at 1 year after treatment for active LN and ≥2 nephritis flares are important risk factors, while mycophenolate and glucocorticoid induction-maintenance treatment regimen was associated with a reduced risk of CKD G3–5 during follow up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus NephritisRenal Insufficiency, ChronicHumansFemaleMaleRetrospective StudiesRisk FactorsDisease ProgressionGlomerular Filtration RateAdultPrevalenceFollow-Up StudiesPrognosisYoung AdultMiddle Aged

Stichwörter der Autor:innen

chronic kidney diseaselupus nephritissystemic lupus erythematosus

Autor:innen und Institutionen

  • Division of Nephrology, School of Clinical Medicine, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR.
  • Division of Nephrology, Department of General Medicine, Khoo Teck Puat Hospital, Singapore, Singapore.

ORCID-Profile: Tak Mao Chan

Förderung

  • Yu Chiu-Kwong Endowed Professorship in Medicine
  • Wai Hung Charitable Foundation
  • Mr and Mrs Tam Wing Fun Edmund Renal Research Fund

Zitieren

APA

Teoh, S. T. Y., Yap, D. Y. H., Tang, C. S. O., & Chan, T. M. (2026). Chronic kidney disease G3–5 in lupus nephritis—prevalence, progression, and risk factors. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfaf201

Vancouver

Teoh STY, Yap DYH, Tang CSO, Chan TM. Chronic kidney disease G3–5 in lupus nephritis—prevalence, progression, and risk factors. Nephrology Dialysis Transplantation. 2026. doi:10.1093/ndt/gfaf201

BibTeX
@article{Teoh2026,
  author = {Teoh, Selene T Y and Yap, Desmond Y H and Tang, Colin S O and Chan, Tak Mao},
  title = {Chronic kidney disease G3–5 in lupus nephritis—prevalence, progression, and risk factors},
  journal = {Nephrology Dialysis Transplantation},
  year = {2026},
  doi = {10.1093/ndt/gfaf201}
}
Kostenlos starten →